vimarsana.com
Home
Live Updates
SYSNAV Healthcare Announces EMA Primary Endpoint Qualificati
SYSNAV Healthcare Announces EMA Primary Endpoint Qualificati
SYSNAV Healthcare Announces EMA Primary Endpoint Qualification of Stride Velocity 95th Centile SV95C for Duchenne Muscular Dystrophy
EMA opinion marks the first Qualification of a digital outcome measure for use as a Primary Endpoint in pivotal drug trials
SV95C is an objective, real-world ...
Related Keywords
France ,
,
European Medicines Agency ,
Primary Endpoint Qualification ,
Stride Velocity ,
Duchenne Muscular Dystrophy ,
Sysnav ,
Healthcare ,
Nnounces ,
Ma ,
Primary ,
Ndpoint ,
Qualification ,
Stride ,
Velocity ,
5th ,
Jgentile ,
V95c ,
Or ,
Duchenne ,
Muscular ,
Dystrophy ,